U.S. Ophthalmic Drugs Market Outlook: Trends, Innovations, and Forecast 2024-2030
The U.S. ophthalmic drugs market size was estimated at USD 15.53 billion in 2023 and is anticipated to grow at a CAGR of 7.4% from 2024 to 2030. The steady growth in the aging population in the country, coupled with an increasing prevalence of eye-related disorders among adults and children, is expected to remain a significant contributing factor to the demand for ophthalmic drugs. As per the 2022 National Health Interview Survey estimates, over 50 million Americans aged 18 years and above stated that they experienced vision loss with varying degrees. Among this demographic, around four million people claimed to have significant vision issues while wearing glasses, while 340,000 stated that they could not see at all. The U.S. market for ophthalmic drugs accounted for a revenue share of 41.1% in the global ophthalmic drug market in 2023. The increasing incidence of diabetes among the population due to sedentary and unhealthy lifestyle patterns h...